Case Study: ADA and Immunogenicity Testing Strategy for a Biosimilar Monoclonal Antibody Program
Introduction: Immunogenicity testing determines whether a biosimilar monoclonal antibody triggers an unwanted immune response, and regulators require this data to […]




